论文信息 - A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer - 字舞流文

A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer

H. Mackay | A. Oza | D. Birle | M. Tsao | D. Hedley | T. Nicklee | L. Siu | J. Wright | M. Vincent | M. Moore | P. Major | C. Townsley | M. Mackenzie | P. Degendorfer